These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 37635980)

  • 1. Alzheimer's disease and its associated risk of bone fractures: a narrative review.
    Zhou BN; Zhang Q; Li M
    Front Endocrinol (Lausanne); 2023; 14():1190762. PubMed ID: 37635980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term thiazide use and risk of low-energy fractures among persons with Alzheimer's disease-nested case-control study.
    Taipale H; Rysä J; Hukkanen J; Koponen M; Tanskanen A; Tiihonen J; Kröger H; Hartikainen S; Tolppanen AM
    Osteoporos Int; 2019 Jul; 30(7):1481-1489. PubMed ID: 30993395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic complexities of bone loss in Alzheimer's disease: a review.
    Frame G; Bretland KA; Dengler-Crish CM
    Connect Tissue Res; 2020 Jan; 61(1):4-18. PubMed ID: 31184223
    [No Abstract]   [Full Text] [Related]  

  • 4. Mind Gaps and Bone Snaps: Exploring the Connection Between Alzheimer's Disease and Osteoporosis.
    Wang HS; Karnik SJ; Margetts TJ; Plotkin LI; Movila A; Fehrenbacher JC; Kacena MA; Oblak AL
    Curr Osteoporos Rep; 2024 Oct; 22(5):483-494. PubMed ID: 38236512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fracture risk in patients with Alzheimer's disease.
    Melton LJ; Beard CM; Kokmen E; Atkinson EJ; O'Fallon WM
    J Am Geriatr Soc; 1994 Jun; 42(6):614-9. PubMed ID: 8201146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in hospitalized, elderly women with Alzheimer's disease: a randomized controlled trial.
    Sato Y; Iwamoto J; Kanoko T; Satoh K
    J Bone Miner Res; 2005 Aug; 20(8):1327-33. PubMed ID: 16007329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of antiresorptive agents for preventing fractures in Japanese patients with an increased fracture risk: review of the literature.
    Iwamoto J; Sato Y; Takeda T; Matsumoto H
    Drugs Aging; 2012 Mar; 29(3):191-203. PubMed ID: 22372723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
    Siris ES; Baim S; Nattiv A
    Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease and risk of hip fracture: a meta-analysis study.
    Zhao Y; Shen L; Ji HF
    ScientificWorldJournal; 2012; 2012():872173. PubMed ID: 22629218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review of the use of bone turnover markers for monitoring the response to osteoporosis treatment: the secondary prevention of fractures, and primary prevention of fractures in high-risk groups.
    Burch J; Rice S; Yang H; Neilson A; Stirk L; Francis R; Holloway P; Selby P; Craig D
    Health Technol Assess; 2014 Feb; 18(11):1-180. PubMed ID: 24534414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is tubal ligation a risk factor for low bone density and increased risk of fracture?
    Fox KM; Cummings SR
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):101-5. PubMed ID: 7847513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's Disease is an Important Risk Factor of Fractures: a Meta-analysis of Cohort Studies.
    Liang Y; Wang L
    Mol Neurobiol; 2017 Jul; 54(5):3230-3235. PubMed ID: 27072352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate.
    Richy F; Ethgen O; Bruyere O; Reginster JY
    Osteoporos Int; 2004 Apr; 15(4):301-10. PubMed ID: 14740153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing osteoporotic fractures in older people.
    McCloskey E
    Practitioner; 2011 Jan; 255(1736):19-22, 2-3. PubMed ID: 21370710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures.
    Stone KL; Seeley DG; Lui LY; Cauley JA; Ensrud K; Browner WS; Nevitt MC; Cummings SR;
    J Bone Miner Res; 2003 Nov; 18(11):1947-54. PubMed ID: 14606506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoporotic fractures: background and prevention strategies.
    Wark JD
    Maturitas; 1996 Mar; 23(2):193-207. PubMed ID: 8735357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and predictors of fractures associated with osteoporosis.
    Lips P
    Am J Med; 1997 Aug; 103(2A):3S-8S; discussion 8S-11S. PubMed ID: 9302892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid beta peptide is elevated in osteoporotic bone tissues and enhances osteoclast function.
    Li S; Liu B; Zhang L; Rong L
    Bone; 2014 Apr; 61():164-75. PubMed ID: 24473375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis.
    Stevenson M; Jones ML; De Nigris E; Brewer N; Davis S; Oakley J
    Health Technol Assess; 2005 Jun; 9(22):1-160. PubMed ID: 15929857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Summary of AHRQ's comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report.
    Levis S; Theodore G
    J Manag Care Pharm; 2012 May; 18(4 Suppl B):S1-15; discussion S13. PubMed ID: 22716221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.